Serum Selenium Level in Patients with Chronic Liver Disease
Galal, G., Ahmad, N., Mohammad, A., Bakrey, R. (2017). Serum Selenium Level in Patients with Chronic Liver Disease. EKB Journal Management System, 21(1), 125-133. doi: 10.21608/smj.2017.40037
Ghada Moustafa Galal; Nagwa Sayed Ahmad; Asmaa Mohammad; Rahma Bakrey. "Serum Selenium Level in Patients with Chronic Liver Disease". EKB Journal Management System, 21, 1, 2017, 125-133. doi: 10.21608/smj.2017.40037
Galal, G., Ahmad, N., Mohammad, A., Bakrey, R. (2017). 'Serum Selenium Level in Patients with Chronic Liver Disease', EKB Journal Management System, 21(1), pp. 125-133. doi: 10.21608/smj.2017.40037
Galal, G., Ahmad, N., Mohammad, A., Bakrey, R. Serum Selenium Level in Patients with Chronic Liver Disease. EKB Journal Management System, 2017; 21(1): 125-133. doi: 10.21608/smj.2017.40037

Serum Selenium Level in Patients with Chronic Liver Disease

Sohag Medical Journal
Article 11, Volume 21, Issue 1, January 2017, Page 125-133  XML PDF (79.23 K)
Document Type: Original Article
DOI: 10.21608/smj.2017.40037
View on SCiNiTO View on SCiNiTO
Authors
Ghada Moustafa Galal1; Nagwa Sayed Ahmad2; Asmaa Mohammad1; Rahma Bakrey1
1Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University.
2Debartment of Biochemistry, Faculty of Medicine, Sohag University.
Abstract
Background: Selenium has been shown to protect against liver necrosis. Selenium deficiency has been involved in the pathogenesis of chronic hepatitis B and C related hepatocellular damage.Serum selenium concentration in cirrhotics was found tobe low, supportive selenium administration may be beneficial for them.Reduced selenium levels result in accumulation of lipid peroxides which accelerate the growth of hepatocellular carcinoma (HCC).
Aim: To study serum selenium level in patients with chronic liver diseases and its relation with severity of theliver diseases.
Patients and Methods: This case–control study was conducted on 100 subjects. The cases were 80 adult patients including chronic hepatitis C and B, liver cirrhosis and HCC.The study also included 20 healthy age and sex-matched subjects served as a control group. Clinical, laboratory and radiological data and blood samples were collected from all participants. Serum selenium concentration was measured and statistical analysis was done.
Results: Selenium concentration was significantly lower in patients compared to healthy controls.Selenium levelwas found low in Chronic HBV, chronic HCV patients and lower incirrhotic group and the lowest in HCC group. Patients with advanced liver cirrhosis (Child B, C) had significantly lower selenium level compared to those with Child A.
Conclusion: Selenium was lower in patients with chronic liver disease and its leveldecreases with the progression of liver disease. Patients with HCC had the lowest Selenium concentration that might correlate with the pathophysiology of HCC. Chronic hepatitis C and B, liver cirrhosis and HCC were independent predictors forSelenium deficiency.
 
Supplementary Files
References
  1. Al-Bader A, Abul H, Hussain T, Al-Moosawi M, Mathew TC and Dashti H (1998): Selenium and liver cirrhosis. Mol Cell Biochem;185: 1-6.
  2. Buljevac M, Romiyc Z, Vuceliyc B, Baniyc M, Krznariyc Z and Pleysco S (1996): Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma. Acta Med Croatica; 50: 11-14.
  3. Burk RF (2002): Selenium, an antioxidant nutrient. NutrClin Care 5: 75-9. 
  4. Burk RF, Early DS, Hill KE, Palmer IS and Boeglin ME (1998): Plasma selenium in patients with cirrhosis. Hepatology; 27: 794-798.
  5. Burk RF, Hill KE (2015): Regulation of selenium metabolism and transport. Annu Rev Nutr;35:109–34
  6. Chappuis P and Poupon J (1991): Le role de selenium dans la defense du stress oxidative. CahNutr Diet; 26: 295-297.
  7. Conri C, Fleury B, Simonoff M, Ducloux  G, Berden B and MorettoP (1988): Selenium zinc et cuivreserique au cours de l’alcoholisme. Ann Med Int; 139: 138-139.
  8. Dworkin B, Rosenthal WS, Jankowski RH, Gordon GG and HaldeaD (1985): Low blood selenium levels in alcoholics with and without advanced liver disease: correlation with clinical and nutritional status. Dig Dis Sci; 30: 838-844.
  9. Ha HL, Shin HJ, Feitelson MA and Yu DY (2010): Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol28; 16(48): 6035–604 28.
  10. Jiang C, Ganther H and Lu J (2000):Monomethyl selenium-specific inhibitionof MMP-2 and VEGF expression: implications for angiogenic switchregulation. MolCarcinog ;29:236-250.
  11. Leccia NT, Richard MJ, Beani JC, Faure H, Monjo A M, Cadet J, Amblard P and Favier A (1993): Protective effect of selenium and zinc on UV-A damage in human skin. PhotochemPhotobiol 58:548-553.
  12. Lin CC, Huang JF, Tsai LY, Huang YL (2006): Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res;109 (1): 15-24.
  13. Martinez- Peinado M, Nogueras-López F, Arcos-Cebrián A, Agil A and Navarro-Alarcón M (2010): Serum selenium levels in cirrhotic patients are not influenced by the disease severity index. Nutr Res 3(8):574–578
  14. Murray M (1996): Selenium. The Encyclopedia of nutritional supplements; 44-53.
  15. Navarro M, López H, Ruiz ML, González S, Pérez V, López MC (1995):  Determination of selenium in serum by hydride generation atomic absorption spectrometry for calculation of daily dietary intake. Sci Total Environ. 15;175(3):245-52
  16. Navarro-Alarcon M and Lopez-Martinez MC (2000): Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ; 249: 347-371.
  17. Ozardali I, Bitiren M, Karakilçik AZ, Zerin M, Aksoy N, Musa D (2004) : Effects of selenium on histopathological and enzymatic changes in experimental liver injury of rats. ExpToxicolPathol.; 56 (1-2): 59-64 .
  18. Rauf N, Tahir S, Dilawar S, Ahmad I and Parvez S (2012): Serum Selenium Concentration in Liver Cirrhotic Patients Suffering from Hepatitis B and C in Pakistan. Biol Trace Elem Res 145:144–150.
  19. Rayman MP (2012): Selenium and human health. Lancet. Mar 31;379 (9822): 1256-68
  20. Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Bjorkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M (2012): Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. HEPATOLOGY; 55: 1112-1121
  21. Spallholz JE, Boylan LM and Larsen HS (1990): Advances in understanding selenium's role in the immune system. Ann N Y AcadSci 587:123–139
  22. Stehbens WE (2004): Oxidative stress in viral hepatitis and AIDS. Exp. Mol. Pathol.; 77(2): 121-32.
  23. Stranges S, Navas-Acien A, Rayman MP and Guallar E (2010): Selenium status and cardiometabolic health: state of the evidence. NutrMetabCardiovasc Dis. Dec;20(10):754-60
  24. Yoshizawa K, Ascherio A, Morris JS, Stampfer MJ, Giovannucci E and Baskett CK (2003): Prospective study of selenium levels in toenails and risk of coronary heart disease in men. Am. J. Epidemiol.; 158(9): 852-60.
  25. Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF and Chen CJ (1999): Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol;150: 367-374.
  26. Yu SY, Zhu YJ and Li WG (1997): Protective role of selenium against hepatitis B. Bio Trace element Res; 56(1): 117-124.
  27. Zhang W, Ramanathan CS, Nadimpalli RG, Bhat AA, Cox AA and Taylor EW (1999): Selenium-dependent glutathione peroxidase modules encoded by RNA viruses. Biol. Trace Elem. Res.; 70: 97-116.
Statistics
Article View: 353
PDF Download: 257